562 related articles for article (PubMed ID: 30467370)
1. Neonatal abstinence syndrome.
Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE
Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370
[TBL] [Abstract][Full Text] [Related]
2. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
3. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
Baldo BA
Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.
Kelty E; Preen DB
CNS Drugs; 2019 Nov; 33(11):1113-1120. PubMed ID: 31686408
[TBL] [Abstract][Full Text] [Related]
5. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
MacMillan KDL
Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310
[TBL] [Abstract][Full Text] [Related]
6. Neonatal opioid withdrawal syndrome.
Sutter MB; Leeman L; Hsi A
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
[TBL] [Abstract][Full Text] [Related]
7. Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis.
Weller AE; Crist RC; Reiner BC; Doyle GA; Berrettini WH
Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32229609
[TBL] [Abstract][Full Text] [Related]
8. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
[TBL] [Abstract][Full Text] [Related]
9. A Practical Approach to Neonatal Opiate Withdrawal Syndrome.
Devlin LA; Davis JM
Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261
[TBL] [Abstract][Full Text] [Related]
10. Neonatal abstinence syndrome: treatment and pediatric outcomes.
Logan BA; Brown MS; Hayes MJ
Clin Obstet Gynecol; 2013 Mar; 56(1):186-92. PubMed ID: 23314720
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
12. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences.
Isaac L; van den Hoogen NJ; Habib S; Trang T
J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100
[TBL] [Abstract][Full Text] [Related]
13. Opioid Use in Pregnancy.
Tobon AL; Habecker E; Forray A
Curr Psychiatry Rep; 2019 Nov; 21(12):118. PubMed ID: 31734808
[TBL] [Abstract][Full Text] [Related]
14. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics.
van Hoogdalem MW; McPhail BT; Hahn D; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):87-103. PubMed ID: 33049155
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy and the Opioid Epidemic.
Haycraft AL
J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):19-23. PubMed ID: 29505087
[TBL] [Abstract][Full Text] [Related]
17. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
18. Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome.
Townsel C; Covault JM; Hussain N; Oncken C; Nold C; Campbell WA
J Matern Fetal Neonatal Med; 2021 Mar; 34(5):670-676. PubMed ID: 31092079
[No Abstract] [Full Text] [Related]
19. Could prenatal food insecurity influence neonatal abstinence syndrome severity?
Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM
Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365
[TBL] [Abstract][Full Text] [Related]
20. Association between Individual versus Community-level Social Vulnerability and Neonatal Opioid Withdrawal Syndrome among Pregnant Individuals Receiving Buprenorphine for Opioid Use Disorder.
Mason I; Abdelwahab M; Stiles A; Wu J; Venkatesh KK; Rood KM
Am J Perinatol; 2024 May; 41(S 01):e3157-e3163. PubMed ID: 37890511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
